News: Symbyax, a combination of Prozac and Zyprexa, approved for treatment-resistant depression
THE FDA HAS APPROVED fluoxetine (Prozac) plus olanzapine (Zyprexa) capsules (Symbyax) as therapy for treatment-resistent depression, defined as a failure to sustain or achieve remission from major depressive disorder (MDD), with two separate trials of different antidepressants of adequate dose and duration in the current episode. An estimated 35% of patients with MDD are afflicted with the treatment-resistant type. Labeling changes to the monographs for olanzapine and fluoxetine reflect the new indication, which allows the option to prescribe the single-pill treatment or two separate medications. The approval was made following two eight-week, double-blind clinical trials in which 40% of patients receiving the two-drug combination responded to therapy, compared with 30% of those receiving only fluoxetine, and 26% receiving only olanzapine.
Waknine Y. FDA approvals: Symbyax and Edluar. Medscape Web site. http://www.medscape.com/viewarticle/590209/. Published March 26, 2009. Accessed April 6, 2009.
MORE ARTICLES IN THIS ISSUE
An Italian study of 112 pediatric patients indicated strong positive reactions to nurses who changed from monochrome to multicolored uniforms, including higher ratings in nurses' performance.
Nurses' opinions on how their facilities treat present-on-admission procedures for their patients and doctors.
RN's nurse entrepreneurship expert answers reader questions on private-pay home health nursing, RN self-employment, and tips on being hired by hospitals as an nurse independent contractor.
The Journal of the National Cancer Institute reported that carriers of breast-cancer mutations should reverse current, early-mammography practice and wait until age 35 to avoid radiation side effects.
Expert nurse witness debates charting points with author of February 2009 documentation feature; praise for March 2009 elder-exploitation and holistic-therapy articles; author of January 2009 Lyme disease article regrets that correction did not clarify that journal staff selected the incorrect art; reader calls for ethnic diversity among RN editorial board; reader disputes medical benefits of circumcision (February 2009); reader proposed possible creative staffing alternatives that would permit older nurses to keep contributing.